Dr. Thomas Ichim, Ph.D.

Immunologist, seasoned biotechnology entrepreneur with a track record of scientific excellence. He has founded/co-founded several biotech companies.

Follow Thomas on Social
Profile picture of dr-thomas-ichim-ph-d

With an impressive portfolio of scientific accomplishments, Dr. Ichim has made a name for himself as a successful biotechnology entrepreneur who founded/co-founded numerous companies throughout his career, such as Batu Biologics, Inc., Medvax Pharma Corp., ToleroTech Inc., bioRASI, and OncoMune LLC.

Dr. Ichim is the esteemed President, Chief Executive Officer & Director of Batu Biologics, Inc., and continues to serve on multiple editorial boards of respected scientific journals while actively reviewing grants, publications, and academic appointments.

With impressive 50-plus patents and patent applications to his name, Dr. Ichim is a pioneer in the field of stem cell therapy and cellular product development with extensive experience navigating FDA regulatory pathways.

With an outstanding 7-year record as President and Chief Scientific Officer of MediStem, Dr. Ichim has demonstrated sheer excellence in product improvement, government filings, and business development by efficiently transitioning a cutting-edge stem cell called Endometrial Regenerative Cell from drug discovery to Phase II clinical tests with the FDA.

Dr. Ichim boasts an extensive academic background, having obtained his BSc in Biology from the University of Waterloo (Ontario, Canada), his MSc in Microbiology and Immunology from the University of Western Ontario (London, Ontario) and, finally a Ph.D. in Immunology at the esteemed University of Sciences Arts & Technology based out of Olveston Monserrat.

Book written by Dr. Thomas Ichim, Ph.D.

Topics discussed by Dr. Thomas Ichim, Ph.D.

Topics discussed by Dr. Thomas Ichim, Ph.D. in books and podcast appearances.